Entry into the tamoxifen prevention trial depends on women's estimates of the population risk of breast cancer

K. Thirlaway*, L. Fallowfield, G. Evans, A. Howell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Cite this